aluates Reports

$ 0.0

Automative

Global Capecitabine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-22N9079

Global Capecitabine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Capecitabine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-22N9079

Report

June 2025

Pages:127

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

TEVA

Mylan NV

Hikma

Hengrui Medicine

Cipla Ltd

Reliance Group

Hetero

Capecitabine Market Size

In 2024, the global market size of Capecitabine was estimated to be worth US$ 1018 million and is forecast to reach approximately US$ 990 million by 2031 with a CAGR of -0.4% during the forecast period 2025-2031.

Capecitabine Market

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the baby. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-fluorouracil and tegafur.

Roche, Teva and Mylan are the top 3 of Capecitabine, with about 87% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Capecitabine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Capecitabine.

The Capecitabine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Capecitabine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Capecitabine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Capecitabine Market Report

Report Metric	Details
Report Name	Capecitabine Market
Forecasted market size in 2031	approximately US$ 990 million
Forecasted years	2025 - 2031
Segment by Type	500 mg 150 mg
Segment by Application	Breast Cancer Colorectal Cancer Stomach Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Teva, Mylan, Hikma, Hengrui Medicine, Cipla, Reliance Group, Hetero
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Capecitabine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Capecitabine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Capecitabine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Capecitabine Market size in 2031?

Ans: The Capecitabine Market size in 2031 will be approximately US$ 990 million.

What is the market share of major companies in Capecitabine Market?

Ans: Roche, Teva and Mylan are the top 3 of Capecitabine, with about 87% market shares.

Who are the main players in the Capecitabine Market report?

Ans: The main players in the Capecitabine Market are Roche, Teva, Mylan, Hikma, Hengrui Medicine, Cipla, Reliance Group, Hetero

What are the Application segmentation covered in the Capecitabine Market report?

Ans: The Applications covered in the Capecitabine Market report are Breast Cancer, Colorectal Cancer, Stomach Cancer

What are the Type segmentation covered in the Capecitabine Market report?

Ans: The Types covered in the Capecitabine Market report are 500 mg, 150 mg

Recommended Reports

Cancer Therapeutics

Chemotherapy Drugs

Cancer Disease Segments

1 Study Coverage

1.1 Capecitabine Product Introduction

1.2 Market by Type

1.2.1 Global Capecitabine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 500 mg

1.2.3 150 mg

1.3 Market by Application

1.3.1 Global Capecitabine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Breast Cancer

1.3.3 Colorectal Cancer

1.3.4 Stomach Cancer

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Capecitabine Market Size Estimates and Forecasts

2.1.1 Global Capecitabine Revenue 2020-2031

2.1.2 Global Capecitabine Sales 2020-2031

2.2 Capecitabine Market Size by Region: 2024 Versus 2031

2.3 Capecitabine Sales by Region (2020-2031)

2.3.1 Global Capecitabine Sales by Region: 2020-2025

2.3.2 Global Capecitabine Sales Forecast by Region (2026-2031)

2.3.3 Global Capecitabine Sales Market Share by Region (2020-2031)

2.4 Capecitabine Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Capecitabine Revenue by Region: 2020-2025

2.4.2 Global Capecitabine Revenue Forecast by Region (2026-2031)

2.4.3 Global Capecitabine Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Capecitabine Sales by Type (2020-2031)

3.1.1.1 Global Capecitabine Sales Volume by Type (2020-2031)

3.1.1.2 Global Capecitabine Sales Market Share by Type (2020-2031)

3.1.2 Global Capecitabine Revenue by Type (2020-2031)

3.1.2.1 Global Capecitabine Revenue by Type (2020-2031)

3.1.2.2 Global Capecitabine Revenue Market Share by Type (2020-2031)

3.1.3 Capecitabine Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Capecitabine Sales by Application (2020-2031)

3.2.1.1 Global Capecitabine Sales Volume by Application (2020-2031)

3.2.1.2 Global Capecitabine Sales Market Share by Application (2020-2031)

3.2.2 Global Capecitabine Revenue by Application (2020-2031)

3.2.2.1 Global Capecitabine Revenue by Application (2020-2031)

3.2.2.2 Global Capecitabine Revenue Market Share by Application (2020-2031)

3.2.3 Capecitabine Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 500 mg of Capecitabine Revenue Market Share by Application

3.3.2 150 mg of Capecitabine Revenue Market Share by Application

4 Global Capecitabine by Manufacturers

4.1 Global Top Capecitabine Manufacturers by Sales (2020-2025)

4.1.1 Global Capecitabine Sales by Manufacturer (2020-2025)

4.1.2 Global Capecitabine Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Capecitabine Manufacturers by Revenue (2020-2025)

4.2.1 Global Capecitabine Revenue by Manufacturer (2020-2025)

4.2.2 Global Capecitabine Revenue Share by Manufacturer (2020-2025)

4.3 Global Capecitabine Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Capecitabine Manufacturers Covered: Ranking by Revenue

4.4.2 Global Capecitabine Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Capecitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Capecitabine Manufacturing Base Distribution, Product Type

4.5.1 Capecitabine Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Capecitabine Market

4.5.3 Manufacturers Capecitabine Product Type and Application

4.5.4 500 mg Market Sales of Capecitabine by Manufacturer

4.5.5 150 mg Market Sales of Capecitabine by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Roche

5.1.1 Roche Company Information

5.1.2 Roche Description, Business Overview

5.1.3 Roche Capecitabine Products Offered

5.1.4 Roche Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Roche Capecitabine Sales by Product in 2024

5.1.6 Roche Capecitabine Sales by Application in 2024

5.1.7 Roche Capecitabine Sales by Geographic Area in 2024

5.1.8 Roche Recent Developments

5.2 Teva

5.2.1 Teva Company Information

5.2.2 Teva Description, Business Overview

5.2.3 Teva Capecitabine Products Offered

5.2.4 Teva Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Teva Capecitabine Sales by Product in 2024

5.2.6 Teva Capecitabine Sales by Application in 2024

5.2.7 Teva Capecitabine Sales by Geographic Area in 2024

5.2.8 Teva Recent Developments

5.3 Mylan

5.3.1 Mylan Company Information

5.3.2 Mylan Description, Business Overview

5.3.3 Mylan Capecitabine Products Offered

5.3.4 Mylan Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Mylan Capecitabine Sales by Product in 2024

5.3.6 Mylan Capecitabine Sales by Application in 2024

5.3.7 Mylan Capecitabine Sales by Geographic Area in 2024

5.3.8 Mylan Recent Developments

5.4 Hikma

5.4.1 Hikma Company Information

5.4.2 Hikma Description, Business Overview

5.4.3 Hikma Capecitabine Products Offered

5.4.4 Hikma Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Hikma Capecitabine Sales by Product in 2024

5.4.6 Hikma Capecitabine Sales by Application in 2024

5.4.7 Hikma Capecitabine Sales by Geographic Area in 2024

5.4.8 Hikma Recent Developments

5.5 Hengrui Medicine

5.5.1 Hengrui Medicine Company Information

5.5.2 Hengrui Medicine Description, Business Overview

5.5.3 Hengrui Medicine Capecitabine Products Offered

5.5.4 Hengrui Medicine Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Hengrui Medicine Capecitabine Sales by Product in 2024

5.5.6 Hengrui Medicine Capecitabine Sales by Application in 2024

5.5.7 Hengrui Medicine Capecitabine Sales by Geographic Area in 2024

5.5.8 Hengrui Medicine Recent Developments

5.6 Cipla

5.6.1 Cipla Company Information

5.6.2 Cipla Description, Business Overview

5.6.3 Cipla Capecitabine Products Offered

5.6.4 Cipla Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Cipla Capecitabine Sales by Product in 2024

5.6.6 Cipla Capecitabine Sales by Application in 2024

5.6.7 Cipla Capecitabine Sales by Geographic Area in 2024

5.6.8 Cipla Recent Developments

5.7 Reliance Group

5.7.1 Reliance Group Company Information

5.7.2 Reliance Group Description, Business Overview

5.7.3 Reliance Group Capecitabine Products Offered

5.7.4 Reliance Group Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Reliance Group Capecitabine Sales by Product in 2024

5.7.6 Reliance Group Capecitabine Sales by Application in 2024

5.7.7 Reliance Group Capecitabine Sales by Geographic Area in 2024

5.7.8 Reliance Group Recent Developments

5.8 Hetero

5.8.1 Hetero Company Information

5.8.2 Hetero Description, Business Overview

5.8.3 Hetero Capecitabine Products Offered

5.8.4 Hetero Capecitabine Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Hetero Capecitabine Sales by Product in 2024

5.8.6 Hetero Capecitabine Sales by Application in 2024

5.8.7 Hetero Capecitabine Sales by Geographic Area in 2024

5.8.8 Hetero Recent Developments

6 North America

6.1 North America Capecitabine Market Size YoY Growth 2020-2031

6.2 North America Capecitabine Market Facts & Figures by Country

6.2.1 North America Capecitabine Sales by Country (2020-2031)

6.2.2 North America Capecitabine Revenue by Country (2020-2031)

6.3 North America Capecitabine Sales by Type (2020-2025)

6.4 North America Capecitabine Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Capecitabine Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Capecitabine Market Facts & Figures by Region

7.2.1 Asia-Pacific Capecitabine Sales by Region (2020-2031)

7.2.2 Asia-Pacific Capecitabine Revenue by Region (2020-2031)

7.3 Asia-Pacific Capecitabine Sales by Type (2020-2025)

7.4 Asia-Pacific Capecitabine Sales by Application (2020-2025)

8 Europe

8.1 Europe Capecitabine Market Size YoY Growth 2020-2031

8.2 Europe Capecitabine Market Facts & Figures by Country

8.2.1 Europe Capecitabine Sales by Country (2020-2031)

8.2.2 Europe Capecitabine Revenue by Country (2020-2031)

8.3 Europe Capecitabine Sales by Type (2020-2025)

8.4 Europe Capecitabine Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Capecitabine Market Size YoY Growth 2020-2031

9.2 Latin America Capecitabine Market Facts & Figures by Country

9.2.1 Latin America Capecitabine Sales by Country (2020-2031)

9.2.2 Latin America Capecitabine Revenue by Country (2020-2031)

9.3 Latin America Capecitabine Sales by Type (2020-2025)

9.4 Latin America Capecitabine Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Capecitabine Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Capecitabine Market Facts & Figures by Country

10.2.1 Middle East and Africa Capecitabine Sales by Country (2020-2031)

10.2.2 Middle East and Africa Capecitabine Revenue by Country (2020-2031)

10.3 Middle East and Africa Capecitabine Sales by Type (2020-2025)

10.4 Middle East and Africa Capecitabine Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Capecitabine Supply Chain Analysis

11.2 Capecitabine Key Raw Materials and Upstream Suppliers

11.3 Capecitabine Clients Analysis

11.4 Capecitabine Sales Channel and Sales Model Analysis

11.4.1 Capecitabine Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Capecitabine Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Capecitabine Distributors

12 Capecitabine Market Dynamics

12.1 Capecitabine Industry Trends

12.2 Capecitabine Market Drivers

12.3 Capecitabine Market Challenges

12.4 Capecitabine Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Roche

TEVA

Mylan NV

Hikma

Hengrui Medicine

Cipla Ltd

Reliance Group

Hetero

List of Tables

Table 1. Global Capecitabine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Capecitabine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Capecitabine Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Capecitabine Sales by Region (2020-2025) & (Kg)

Table 5. Global Capecitabine Sales Forecast by Region (2026-2031) & (Kg)

Table 6. Global Capecitabine Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Capecitabine Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Capecitabine Sales Volume by Type (2020-2025) & (Kg)

Table 9. Global Capecitabine Sales Volume by Type (2026-2031) & (Kg)

Table 10. Global Capecitabine Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Capecitabine Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Capecitabine Sales Volume by Application (2020-2025) & (Kg)

Table 13. Global Capecitabine Sales Volume by Application (2026-2031) & (Kg)

Table 14. Global Capecitabine Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Capecitabine Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Capecitabine Sales by Manufacturer (2020-2025) & (Kg)

Table 17. Global Capecitabine Sales Share by Manufacturer (2020-2025)

Table 18. Capecitabine Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Capecitabine Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Capecitabine Price (2020-2025) & (USD/g)

Table 21. Ranking of Global Top Capecitabine Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Capecitabine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Capecitabine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Capecitabine as of 2024)

Table 24. Capecitabine Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Capecitabine Market

Table 26. Manufacturers Capecitabine Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Roche Company Information

Table 29. Roche Description and Business Overview

Table 30. Roche Capecitabine Product

Table 31. Roche Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 32. Roche Sales Proportion of Capecitabine by Product in 2024

Table 33. Roche Sales Proportion of Capecitabine by Application in 2024

Table 34. Roche Sales Proportion of Capecitabine by Geographic Area in 2024

Table 35. Roche Recent Developments

Table 36. Teva Company Information

Table 37. Teva Description and Business Overview

Table 38. Teva Capecitabine Product

Table 39. Teva Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 40. Teva Sales Proportion of Capecitabine by Product in 2024

Table 41. Teva Sales Proportion of Capecitabine by Application in 2024

Table 42. Teva Sales Proportion of Capecitabine by Geographic Area in 2024

Table 43. Teva Recent Developments

Table 44. Mylan Company Information

Table 45. Mylan Description and Business Overview

Table 46. Mylan Capecitabine Product

Table 47. Mylan Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 48. Mylan Sales Proportion of Capecitabine by Product in 2024

Table 49. Mylan Sales Proportion of Capecitabine by Application in 2024

Table 50. Mylan Sales Proportion of Capecitabine by Geographic Area in 2024

Table 51. Mylan Recent Developments

Table 52. Hikma Company Information

Table 53. Hikma Description and Business Overview

Table 54. Hikma Capecitabine Product

Table 55. Hikma Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 56. Hikma Sales Proportion of Capecitabine by Product in 2024

Table 57. Hikma Sales Proportion of Capecitabine by Application in 2024

Table 58. Hikma Sales Proportion of Capecitabine by Geographic Area in 2024

Table 59. Hikma Recent Developments

Table 60. Hengrui Medicine Company Information

Table 61. Hengrui Medicine Description and Business Overview

Table 62. Hengrui Medicine Capecitabine Product

Table 63. Hengrui Medicine Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 64. Hengrui Medicine Sales Proportion of Capecitabine by Product in 2024

Table 65. Hengrui Medicine Sales Proportion of Capecitabine by Application in 2024

Table 66. Hengrui Medicine Sales Proportion of Capecitabine by Geographic Area in 2024

Table 67. Hengrui Medicine Recent Developments

Table 68. Cipla Company Information

Table 69. Cipla Description and Business Overview

Table 70. Cipla Capecitabine Product

Table 71. Cipla Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 72. Cipla Sales Proportion of Capecitabine by Product in 2024

Table 73. Cipla Sales Proportion of Capecitabine by Application in 2024

Table 74. Cipla Sales Proportion of Capecitabine by Geographic Area in 2024

Table 75. Cipla Recent Developments

Table 76. Reliance Group Company Information

Table 77. Reliance Group Description and Business Overview

Table 78. Reliance Group Capecitabine Product

Table 79. Reliance Group Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 80. Reliance Group Sales Proportion of Capecitabine by Product in 2024

Table 81. Reliance Group Sales Proportion of Capecitabine by Application in 2024

Table 82. Reliance Group Sales Proportion of Capecitabine by Geographic Area in 2024

Table 83. Reliance Group Recent Developments

Table 84. Hetero Company Information

Table 85. Hetero Description and Business Overview

Table 86. Hetero Capecitabine Product

Table 87. Hetero Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 88. Hetero Sales Proportion of Capecitabine by Product in 2024

Table 89. Hetero Sales Proportion of Capecitabine by Application in 2024

Table 90. Hetero Sales Proportion of Capecitabine by Geographic Area in 2024

Table 91. Hetero Recent Developments

Table 92. North America Capecitabine Sales by Country (2020-2025) & (Kg)

Table 93. North America Capecitabine Sales by Country (2026-2031) & (Kg)

Table 94. North America Capecitabine Revenue by Country (2020-2025) & (US$ Million)

Table 95. North America Capecitabine Revenue by Country (2026-2031) & (US$ Million)

Table 96. North America Capecitabine Sales by Type (2020-2025) & (Kg)

Table 97. North America Capecitabine Sales by Application (2020-2025) & (Kg)

Table 98. Asia-Pacific Capecitabine Sales by Region (2020-2025) & (Kg)

Table 99. Asia-Pacific Capecitabine Sales by Region (2026-2031) & (Kg)

Table 100. Asia-Pacific Capecitabine Revenue by Region (2020-2025) & (US$ Million)

Table 101. Asia-Pacific Capecitabine Revenue by Region (2026-2031) & (US$ Million)

Table 102. Asia-Pacific Capecitabine Sales by Type (2020-2025) & (Kg)

Table 103. Asia-Pacific Capecitabine Sales by Application (2020-2025) & (Kg)

Table 104. Europe Capecitabine Sales by Country (2020-2025) & (Kg)

Table 105. Europe Capecitabine Sales by Country (2026-2031) & (Kg)

Table 106. Europe Capecitabine Revenue by Country (2020-2025) & (US$ Million)

Table 107. Europe Capecitabine Revenue by Country (2026-2031) & (US$ Million)

Table 108. Europe Capecitabine Sales by Type (2020-2025) & (Kg)

Table 109. Europe Capecitabine Sales by Application (2020-2025) & (Kg)

Table 110. Latin America Capecitabine Sales by Country (2020-2025) & (Kg)

Table 111. Latin America Capecitabine Sales by Country (2026-2031) & (Kg)

Table 112. Latin America Capecitabine Revenue by Country (2020-2025) & (US$ Million)

Table 113. Latin America Capecitabine Revenue by Country (2026-2031) & (US$ Million)

Table 114. Latin America Capecitabine Sales by Type (2020-2025) & (Kg)

Table 115. Latin America Capecitabine Sales by Application (2020-2025) & (Kg)

Table 116. Middle East and Africa Capecitabine Sales by Country (2020-2025) & (Kg)

Table 117. Middle East and Africa Capecitabine Sales by Country (2026-2031) & (Kg)

Table 118. Middle East and Africa Capecitabine Revenue by Country (2020-2025) & (US$ Million)

Table 119. Middle East and Africa Capecitabine Revenue by Country (2026-2031) & (US$ Million)

Table 120. Middle East and Africa Capecitabine Sales by Type (2020-2025) & (Kg)

Table 121. Middle East and Africa Capecitabine Sales by Application (2020-2025) & (Kg)

Table 122. Capecitabine Key Raw Materials, Industry Status and Trend

Table 123. Capecitabine Key Raw Materials and Upstream Suppliers

Table 124. Capecitabine Clients Status and Trend

Table 125. Capecitabine Typical Clients

Table 126. Capecitabine Distributors

Table 127. Capecitabine Market Trends

Table 128. Capecitabine Market Drivers

Table 129. Capecitabine Market Challenges

Table 130. Capecitabine Market Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Capecitabine Product Picture

Figure 2. Global Capecitabine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Capecitabine Sales Market Share by Type in 2024 & 2031

Figure 4. 500 mg Product Picture

Figure 5. 150 mg Product Picture

Figure 6. Global Capecitabine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Capecitabine Sales Market Share by Application in 2024 & 2031

Figure 8. Breast Cancer

Figure 9. Colorectal Cancer

Figure 10. Stomach Cancer

Figure 11. Capecitabine Report Years Considered

Figure 12. Global Capecitabine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Capecitabine Market Size 2020-2031 (US$ Million)

Figure 14. Global Capecitabine Sales 2020-2031 (Kg)

Figure 15. Global Capecitabine Sales Market Share Forecast by Region (2020-2031)

Figure 16. Global Capecitabine Revenue Market Share by Region (2020-2031)

Figure 17. Global Capecitabine Sales Market Share Forecast by Type (2020-2031)

Figure 18. Global Capecitabine Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Capecitabine Average Selling Price (ASP) by Type (2020-2025) & (USD/g)

Figure 20. Global Capecitabine Sales Market Share Forecast by Application (2020-2031)

Figure 21. Global Capecitabine Revenue Market Share Forecast by Application (2020-2031)

Figure 22. Capecitabine Average Selling Price (ASP) by Application (2020-2025) & (USD/g)

Figure 23. 500 mg of Capecitabine Revenue Market Share by Application, 2024 VS 2031

Figure 24. 150 mg of Capecitabine Revenue Market Share by Application, 2024 VS 2031

Figure 25. Global Capecitabine Sales Share by Manufacturer in 2024

Figure 26. Capecitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. 500 mg Market Sales Proportion by Manufacturer in 2024

Figure 28. 150 mg Market Sales Proportion by Manufacturer in 2024

Figure 29. North America Capecitabine Revenue 2020-2031 (US$ Million)

Figure 30. North America Capecitabine Sales Market Share by Type (2020-2025)

Figure 31. North America Capecitabine Sales Market Share by Application (2020-2025)

Figure 32. Asia-Pacific Capecitabine Revenue 2020-2031 (US$ Million)

Figure 33. Asia-Pacific Capecitabine Sales Market Share by Region (2020-2031)

Figure 34. Asia-Pacific Capecitabine Revenue Market Share by Region (2020-2031)

Figure 35. Asia-Pacific Capecitabine Sales Market Share by Type (2020-2025)

Figure 36. Asia-Pacific Capecitabine Sales Market Share by Application (2020-2025)

Figure 37. Europe Capecitabine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 38. Europe Capecitabine Sales Market Share by Country (2020-2031)

Figure 39. Europe Capecitabine Revenue Market Share by Country (2020-2031)

Figure 40. Europe Capecitabine Sales Market Share by Type (2020-2025)

Figure 41. Europe Capecitabine Sales Market Share by Application (2020-2025)

Figure 42. Latin America Capecitabine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Latin America Capecitabine Sales Market Share by Country (2020-2031)

Figure 44. Latin America Capecitabine Revenue Market Share by Country (2020-2025)

Figure 45. Latin America Capecitabine Sales Market Share by Type (2020-2025)

Figure 46. Latin America Capecitabine Sales Market Share by Application (2020-2025)

Figure 47. Middle East and Africa Capecitabine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 48. Middle East and Africa Capecitabine Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Capecitabine Revenue Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Capecitabine Sales Market Share by Type (2020-2025)

Figure 51. Middle East and Africa Capecitabine Sales Market Share by Application (2020-2025)

Figure 52. Capecitabine Supply Chain (Upstream and Downstream Market)

Figure 53. Global Production Market Share of Capecitabine Raw Materials by Region in 2024

Figure 54. Capecitabine Distribution Channels

Figure 55. Global Capecitabine Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 56. Global Capecitabine Percentage 2020-2031: Online Sales VS Offline Sales

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Capecitabine Fumarate Market Research Report 2025

Pharma Grade Capecitabine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Chemotherapy Drugs Market Research Report 2025

Global Metastatic Cancer Treat Drug Market Research Report 2025

Global Oral Cytotoxic Drug Market Research Report 2025

Global Irinotecan Market Research Report 2024

Global 5 Fluorouracil Market Insights Forecast to 2030

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Vincristine Market Research Report 2024

Global Oral Capecitabine Market Research Report 2024

Global Capecitabine API Market Research Report 2024

Global Gemcitabine Powder For Injection Market Research Report 2024

Global Doxifluridine Market Research Report 2024

Global Batilol Tablets Market Research Report 2024

Global Cetuximab Market Insights Forecast to 2030

Metastatic Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vinorelbine Market Research Report 2024

Imatinib Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Crizotinib Drugs Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions